AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Up 1.8% – Time to Buy?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report)’s stock price rose 1.8% during mid-day trading on Tuesday . The stock traded as high as $15.09 and last traded at $15.09. Approximately 592,107 shares were traded during mid-day trading, a decline of 20% from the average daily volume of 742,256 shares. The stock had previously closed at $14.83.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

The business has a 50 day moving average of $15.49 and a 200 day moving average of $17.02. The firm has a market capitalization of $377.25 million, a price-to-earnings ratio of 17.67 and a beta of -0.66.

Institutional Investors Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Hedge funds have recently bought and sold shares of the company. J.Safra Asset Management Corp acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the 2nd quarter worth $48,000. Ethos Financial Group LLC grew its stake in AGF U.S. Market Neutral Anti-Beta Fund by 24.7% in the second quarter. Ethos Financial Group LLC now owns 25,229 shares of the company’s stock valued at $446,000 after acquiring an additional 5,004 shares during the period. L.M. Kohn & Company bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the second quarter worth about $570,000. Magnolia Private Wealth LLC increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 266.0% in the second quarter. Magnolia Private Wealth LLC now owns 68,189 shares of the company’s stock worth $1,207,000 after acquiring an additional 49,560 shares in the last quarter. Finally, PMV Capital Advisers LLC raised its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 13.1% during the second quarter. PMV Capital Advisers LLC now owns 151,160 shares of the company’s stock worth $2,676,000 after purchasing an additional 17,455 shares during the period.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

See Also

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.